We are live on
!
Find out more
RAM
Roanoke Asset Management Portfolio holdings
AUM
$292M
1-Year Est. Return
6.35%
This Fund
S&P 500
This Quarter
Est. Return
+7.46%
1 Year Est. Return
+6.35%
3 Year Est. Return
+50.34%
5 Year Est. Return
+191.13%
10 Year Est. Return
+336.09%
AUM
$210M
AUM Growth
-$9.83M
(-4.5%)
Cap. Flow
-$23.3M
Cap. Flow
% of AUM
-11.09%
Top 10 Holdings %
Top 10 Hldgs %
34.31%
Holding
103
New
2
Increased
14
Reduced
61
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Natural Resources
CNQ
|
+$1.67M |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.08M |
| 3 |
Alkermes
ALKS
|
+$700K |
| 4 |
WFT
Weatherford International plc
WFT
|
+$304K |
| 5 |
AstraZeneca
AZN
|
+$292K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$5.02M |
| 2 |
Royal Caribbean
RCL
|
+$1.2M |
| 3 |
Amgen
AMGN
|
+$1M |
| 4 |
Bank of America
BAC
|
+$942K |
| 5 |
Walt Disney
DIS
|
+$929K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.42% |
| 2 | Technology | 16.02% |
| 3 | Healthcare | 15.88% |
| 4 | Consumer Discretionary | 12.3% |
| 5 | Energy | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISF.CL
76
DELISTED
ING Groep NV
ISF.CL
| $325K | 0.15% |
12,700
| – | – |
|
77
Johnson & Johnson
JNJ
$640B
| $324K | 0.15% |
2,600
-100
| -4% | -$11.9K |
|
|
78
AstraZeneca
AZN
$269B
| $312K | 0.15% |
+5,015
| New | +$292K |
|
|
ENLK
79
DELISTED
EnLink Midstream Partners, LP
ENLK
| $309K | 0.15% |
16,900
-650
| -4% | -$12K |
|
80
MPLX
MPLX
$58.6B
| $308K | 0.15% |
8,544
| – | – |
|
81
LivePerson
LPSN
$22M
| $303K | 0.14% |
2,953
-54
| -2% | -$5.77K |
|
82
Automatic Data Processing
ADP
$109B
| $292K | 0.14% |
2,855
-15
| -0.5% | -$1.53K |
|
83
Energy Transfer Partners
ET
$69.5B
| $276K | 0.13% |
14,000
| – | – |
|
|
CFC.PRB.CL
84
DELISTED
Countrywide Capital V
CFC.PRB.CL
| $258K | 0.12% |
10,000
| – | – |
|
85
Williams-Sonoma
WSM
$27.5B
| $255K | 0.12% |
9,500
-500
| -5% | -$12.2K |
|
|
AET
86
DELISTED
Aetna Inc
AET
| $255K | 0.12% |
2,000
| – | – |
|
87
Mid-America Apartment Communities
MAA
$16B
| $249K | 0.12% |
2,450
| – | – |
|
88
Ford
F
$60.9B
| $244K | 0.12% |
20,995
-11,000
| -34% | -$137K |
|
89
GE Aerospace
GE
$364B
| $242K | 0.12% |
1,696
-483
| -22% | -$69.9K |
|
90
FIVE9
FIVN
$2.08B
| $181K | 0.09% |
11,000
| – | – |
|
91
Gran Tierra Energy
GTE
$236M
| $95K | 0.05% |
3,600
| – | – |
|
|
92
Target
TGT
$66.3B
| – | – |
-69,480
| Closed | -$5.02M |
|
|
RMKR
93
DELISTED
RAINMAKER SYSTEMS INC NEW
RMKR
| $0 | ﹤0.01% |
151,100
| – | – |
|
|
TXCC
94
DELISTED
TRANSWITCH CORP NEW COM STK (DE)
TXCC
| $0 | ﹤0.01% |
97,836
| – | – |
|
Similar funds
WFA
HCA
WGCA
RI
BCM
PPWP
IAM
UFA
Roanoke Asset Management's Q1 2017 Portfolio in Review
As of Q1 2017, Roanoke Asset Management held 103 positions worth $210M, down 4.5% from $220M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Roanoke Asset Management withdrew a net $23.3M in Q1 2017, closing 1 position and reducing 61 holdings. Its most notable exit was Target, an estimated $5.02M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Roanoke Asset Management opened a new position in AstraZeneca worth $312K.
- Roanoke Asset Management's largest Q1 2017 buy was AstraZeneca: 5,015 shares worth $312K.
- Roanoke Asset Management added most to Canadian Natural Resources in Q1 2017, an estimated $1.67M increase.
- Roanoke Asset Management's biggest Q1 2017 reduction was Royal Caribbean, cutting an estimated $1.2M.
- Roanoke Asset Management fully exited Target in Q1 2017, selling an estimated $5.02M.
- Roanoke Asset Management's ten largest holdings make up 34% of its $210M portfolio in Q1 2017.
- Roanoke Asset Management opened 2 new positions and closed 1 in Q1 2017.
- Roanoke Asset Management's portfolio value fell 4.5% quarter-over-quarter to $210M.
Based on Roanoke Asset Management's 13F filing for Q1 2017, filed 21 Apr 2017.